Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial

Abstract Introduction: Anxiety and fear are common among pregnant women undergoing cesarean delivery. In addition to psychologically unpleasant, they can elicit endocrine and metabolic changes. Administration of benzodiazepines in this patient group is uncommon and investigation focusing on the topic is rare. This study aimed to determine anxiolysis efficacy of low-dose midazolam administered preoperatively, right before cesarean delivery, and to evaluate whether its administration impacts neonatal vitality, maternal consciousness, and recall of the moment the baby was born. Method: Fifty pregnant women with indication for cesarean delivery were included in this randomized, double-blind, placebo-controlled clinical study and allocated into two groups of 25 participants each (Midazolam and Control group). Midazolam (0.0125 mg.kg-1) or a placebo solution was administered immediately before spinal anesthesia and the anxiolytic effect was assessed using a visual analogue scale before and after administration. We registered the Apgar score at 1 and 5 minutes, the Ramsay scale and recall of the moment of birth, that was assessed 90 minutes after birth. Results: Pregnant women from the Midazolam group presented a 1.3-point reduction in anxiety on the visual analogue scale, while the Control group showed virtually no change (p = 0.027). We observed no statistically significant changes in Apgar scores, level of maternal consciousness and recall of the moment of delivery. Conclusions: Low-dose midazolam can provide anxiety management in pregnant women undergoing cesarean delivery with no significant undesirable effects.

Saved in:
Bibliographic Details
Main Authors: Oliveira,Pedro Solfa Campos, Sant’Anna,Beatriz Cesars, Seixas,Náira Bueno, Mendonça,José Alexandre
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Anestesiologia (SBA) 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2352-22912022000400450
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2352-22912022000400450
record_format ojs
spelling oai:scielo:S2352-229120220004004502022-07-19Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trialOliveira,Pedro Solfa CamposSant’Anna,Beatriz CesarsSeixas,Náira BuenoMendonça,José Alexandre Anxiety Cesarean section Pregnant women Midazolam Abstract Introduction: Anxiety and fear are common among pregnant women undergoing cesarean delivery. In addition to psychologically unpleasant, they can elicit endocrine and metabolic changes. Administration of benzodiazepines in this patient group is uncommon and investigation focusing on the topic is rare. This study aimed to determine anxiolysis efficacy of low-dose midazolam administered preoperatively, right before cesarean delivery, and to evaluate whether its administration impacts neonatal vitality, maternal consciousness, and recall of the moment the baby was born. Method: Fifty pregnant women with indication for cesarean delivery were included in this randomized, double-blind, placebo-controlled clinical study and allocated into two groups of 25 participants each (Midazolam and Control group). Midazolam (0.0125 mg.kg-1) or a placebo solution was administered immediately before spinal anesthesia and the anxiolytic effect was assessed using a visual analogue scale before and after administration. We registered the Apgar score at 1 and 5 minutes, the Ramsay scale and recall of the moment of birth, that was assessed 90 minutes after birth. Results: Pregnant women from the Midazolam group presented a 1.3-point reduction in anxiety on the visual analogue scale, while the Control group showed virtually no change (p = 0.027). We observed no statistically significant changes in Apgar scores, level of maternal consciousness and recall of the moment of delivery. Conclusions: Low-dose midazolam can provide anxiety management in pregnant women undergoing cesarean delivery with no significant undesirable effects.info:eu-repo/semantics/openAccessSociedade Brasileira de Anestesiologia (SBA)Brazilian Journal of Anesthesiology v.72 n.4 20222022-07-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2352-22912022000400450en10.1016/j.bjane.2021.07.039
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Oliveira,Pedro Solfa Campos
Sant’Anna,Beatriz Cesars
Seixas,Náira Bueno
Mendonça,José Alexandre
spellingShingle Oliveira,Pedro Solfa Campos
Sant’Anna,Beatriz Cesars
Seixas,Náira Bueno
Mendonça,José Alexandre
Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
author_facet Oliveira,Pedro Solfa Campos
Sant’Anna,Beatriz Cesars
Seixas,Náira Bueno
Mendonça,José Alexandre
author_sort Oliveira,Pedro Solfa Campos
title Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
title_short Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
title_full Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
title_fullStr Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
title_full_unstemmed Low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
title_sort low-dose midazolam for anxiolysis for pregnant women undergoing cesarean delivery: a randomized trial
description Abstract Introduction: Anxiety and fear are common among pregnant women undergoing cesarean delivery. In addition to psychologically unpleasant, they can elicit endocrine and metabolic changes. Administration of benzodiazepines in this patient group is uncommon and investigation focusing on the topic is rare. This study aimed to determine anxiolysis efficacy of low-dose midazolam administered preoperatively, right before cesarean delivery, and to evaluate whether its administration impacts neonatal vitality, maternal consciousness, and recall of the moment the baby was born. Method: Fifty pregnant women with indication for cesarean delivery were included in this randomized, double-blind, placebo-controlled clinical study and allocated into two groups of 25 participants each (Midazolam and Control group). Midazolam (0.0125 mg.kg-1) or a placebo solution was administered immediately before spinal anesthesia and the anxiolytic effect was assessed using a visual analogue scale before and after administration. We registered the Apgar score at 1 and 5 minutes, the Ramsay scale and recall of the moment of birth, that was assessed 90 minutes after birth. Results: Pregnant women from the Midazolam group presented a 1.3-point reduction in anxiety on the visual analogue scale, while the Control group showed virtually no change (p = 0.027). We observed no statistically significant changes in Apgar scores, level of maternal consciousness and recall of the moment of delivery. Conclusions: Low-dose midazolam can provide anxiety management in pregnant women undergoing cesarean delivery with no significant undesirable effects.
publisher Sociedade Brasileira de Anestesiologia (SBA)
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2352-22912022000400450
work_keys_str_mv AT oliveirapedrosolfacampos lowdosemidazolamforanxiolysisforpregnantwomenundergoingcesareandeliveryarandomizedtrial
AT santannabeatrizcesars lowdosemidazolamforanxiolysisforpregnantwomenundergoingcesareandeliveryarandomizedtrial
AT seixasnairabueno lowdosemidazolamforanxiolysisforpregnantwomenundergoingcesareandeliveryarandomizedtrial
AT mendoncajosealexandre lowdosemidazolamforanxiolysisforpregnantwomenundergoingcesareandeliveryarandomizedtrial
_version_ 1756441253569888256